UNIQUELY SAVING LIVES

Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique, biologic medicines, versus synthetic or chemical medicines, because production begins with plasma, a biologic starting material. These unique therapies replace missing or deficient proteins found in plasma, allowing their recipients to lead healthier and more productive lives.